MoneyWorks4Me

Kimia Biosciences gets permission to manufacture new API ‘Bilastine’

16 Mar 2021 Evaluate

Kimia Biosciences has been granted permission to manufacture new API for sale or for distribution' namely Bilastine by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..